InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,236.00
(
-0.12%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
-0.72%
)
Bitcoin
64,109.65
(
-1.10%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Investor100

Send PM Follow Ignore
Followers 505
Posts 6242
Boards Moderated 0
Alias Born 09/20/2006

Investor100

Re: $heff post# 51246

Monday, 02/27/2012 7:14:57 AM

Monday, February 27, 2012 7:14:57 AM

Post# of 97239
CBRX:Watson Receives Complete Response Letter from FDA for Progesterone Vaginal Gel 8%

PPS:.79

PARSIPPANY and LIVINGSTON, N.J., Feb. 27, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI - News) and Columbia Laboratories, Inc. (Nasdaq: CBRX - News) today confirmed that, as expected, Watson has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA 22-139) for progesterone vaginal gel 8% for use in the reduction of risk of preterm birth in women with a singleton gestation and a short uterine cervical length in the mid-trimester of pregnancy.

http://finance.yahoo.com/news/Watson-Receives-Complete-prnews-583477954.html?x=0

Investor 100
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up